You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
据报中国驻美大使馆开始接受赴华人士外国疫苗接种记录
阿思达克 04-21 12:02
内地开始接受拟赴华人士在美国接种美国药厂生产的新冠疫苗的接种记录。《路透》报道,中国驻美国大使馆於4月16日的一项通知中表示,该使馆目前仍负责审核乘达拉斯航班赴华乘客的「双检测」证明。拟赴华人士如接种灭活疫苗後核酸检测阴性、IgM抗体检测阳性,可正常申请健康码。

该通知并称,美国现有的辉瑞(PFE.US)、莫德纳(MRNA.US)及强生(JNJ.US)均属非灭活疫苗。按要求,辉瑞、莫德纳疫苗需接种二剂,强生疫苗需接种一剂。拟赴华人士如选择接种,需在完成规定接种次数後安排赴华行程。报道称指导意见意味旅行要求开始放宽。

中国未批准非中国制药商研发的疫苗於国内使用。不过有报道指,中国计划在今年7月前批准使用BioNTech(BNTX.US)新冠疫苗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account